(Q36472645)

14 August 2017

Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results (English)

1 reference

14 August 2017

1 reference

8

Michelle Petri

1 reference

14 August 2017

7

Michael D Lockshin

1 reference

14 August 2017

9

Joan T Merrill

1 reference

14 August 2017

Cecile M Yelnik

1

1 reference

14 August 2017

Carl A Laskin

2

1 reference

14 August 2017

T Flint Porter

3

1 reference

14 August 2017

D Ware Branch

4

1 reference

14 August 2017

Jill P Buyon

5

1 reference

14 August 2017

Marta M Guerra

6

1 reference

14 August 2017

Lisa R Sammaritano

10

1 reference

14 August 2017

Mimi Y Kim

11

1 reference

14 August 2017

Jane E Salmon

12

1 reference

14 August 2017

12 January 2016

1 reference

14 August 2017

Lupus science & medicine

1 reference

14 August 2017

3

1 reference

14 August 2017

1

1 reference

14 August 2017

e000131

1 reference

Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716418

The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study

30 September 2017

1 reference

12 December 2020

Antiphospholipid syndrome

1 reference

12 December 2020

Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome

1 reference

12 December 2020

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study

1 reference

12 December 2020

10.1136/LUPUS-2015-000131

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

26835148

1 reference